Manufacturing Chemist Stand Side with Almac

Published: 6-Nov-2023 Featured companies: Almac Group
Manufacturing Marketing

At the recent CPHI Barcelona trade show Manufacturing Chemist Stand Side caught up with John McQuaid, President and Managing Director of Almac Pharma Services

Taking time out of his busy schedule, John McQuaid spoke to Manufacturing Chemist Stand Side to talk about the company's role and services, why they exhibit at CPHI Barcelona and what their future plans are.

Manufacturing Chemist Stand Side...

'Manufacturing Chemist Stand Side' is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of 'Manufacturing Chemist Stand Side' contact Don Phares on +44 207 193 3219 or via email don@hpcimedia.com.

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

Read more
The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA

Trending Articles

  1. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  2. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  3. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  4. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging
  5. Theranexus and Exeltis sign commercialisation agreement for neurological disorder-targeting TX01 The therapeutic will be used to target Gaucher and Niemann-Pick type C, with Exeltis attaining the exclusive rights to the marketing and distribution of TX01 across the Europe, South America and the Middle East

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac Sciences awarded Life Sciences Innovative Manufacturing Fund grant

Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant
Manufacturing

BGEN awarded small molecule production facility contract by Almac Sciences

This build will enhance Almac Sciences' active pharmaceutical ingredient (API) production capabilities
Manufacturing

Almac Group releases details of $97m HQ expansion in Northern Ireland

The £80 million expansion has been designed by the pharmaceutical services provider to provide a 140,000 sqft capacity increase for development and manufacturing facilities
Manufacturing

Asynt and Almac team up on bespoke reactor vessels

The two companies have teamed up design and supply a range of bespoke reactor vessels, highlighting the benefits of utilising Asynt's lab vessels to streamline Almac Sciences' scale-up process
Manufacturing

Almac updates software with new content for cancer research

The updates include 16 new gene expression signatures across the Hallmarks of Cancer, improved functionality with online data access and simplified reporting
Manufacturing

Almac launches IXRS3 partnership network

“Managing a mix of technologies throughout the course of a clinical trial is a common pain point for sponsors and service providers."
Subscribe now